Andrew R. Allen, See Remarks at Clovis Oncology, Inc. (CLVS), bought 7,413 shares at $13.00 ($50K) on 2011-11-21, disclosed to the SEC on 2011-11-21.
Open-market purchase of $50k CLVS by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,567 | $0 | 0.0% |
| 2 | $13.00 | 3,846 | $50K | 100.0% |
| Total | $6.74 avg | 7,413 | $50K | 100% |
| Filing → |
| CLVS | SELL | 2015-01-21 | $5.3M | — | Filing → |
| CLVS | SELL | 2015-01-20 | $3.2M | — | Filing → |
| CLVS | SELL | 2013-06-07 | $1.5M | — | Filing → |